middle.news
How Algorae’s A$318,771 R&D Rebate Could Accelerate AI Drug Discovery
8:57am on Friday 6th of June, 2025 AEST
•
Healthcare
Read Story
How Algorae’s A$318,771 R&D Rebate Could Accelerate AI Drug Discovery
8:57am on Friday 6th of June, 2025 AEST
Key Points
Received A$318,771 R&D tax rebate for FY2024
Funds to support AI-driven drug discovery and pharmaceutical development
Non-dilutive cash injection strengthens financial position
Supports pursuit of early revenue opportunities
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE